TD Cowen Downgrades Humana to Hold, Lowers Price Target to $261
Portfolio Pulse from Benzinga Newsdesk
TD Cowen has downgraded Humana from Buy to Hold and significantly lowered its price target from $402 to $261, indicating a less optimistic outlook on the company's stock performance.
October 07, 2024 | 3:47 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TD Cowen analyst Gary Taylor has downgraded Humana from Buy to Hold and reduced the price target from $402 to $261. This suggests a less favorable view on Humana's stock performance.
The downgrade from Buy to Hold and the significant reduction in the price target from $402 to $261 by TD Cowen indicates a negative reassessment of Humana's future stock performance. This is likely to impact investor sentiment and could lead to a short-term decline in Humana's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100